vs
NEOGEN CORP（NEOG）与null（SWIM）财务数据对比。点击上方公司名可切换其他公司
NEOGEN CORP的季度营收约是null的1.9倍（$224.7M vs $117.3M），NEOGEN CORP净利率更高（-7.1% vs -7.3%，领先0.2%），null同比增速更快（5.3% vs -2.8%），过去两年NEOGEN CORP的营收复合增速更高（-0.9% vs -14.4%）
Neogen Corporation是一家1982年成立、总部位于美国密歇根州兰辛的跨国食品安全企业，专注提供各类检测试剂盒及相关产品，用于筛查食品中的有害成分。目前业务覆盖美国、加拿大、英国、欧洲部分地区、墨西哥、巴西、印度、中国等多个国家，旗下拥有超100款药物检测试剂盒产品，可检测约300种相关违禁物质。
该企业是一家源自美国的跨国律师事务所，1934年创立于加利福尼亚州洛杉矶，在诉讼业务、公司法务以及监管合规法律领域拥有深厚的行业积累与知名度，是全球颇具影响力的综合性律所之一。
NEOG vs SWIM — 直观对比
营收规模更大
NEOG
是对方的1.9倍
$117.3M
营收增速更快
SWIM
高出8.1%
-2.8%
净利率更高
NEOG
高出0.2%
-7.3%
两年增速更快
NEOG
近两年复合增速
-14.4%
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $224.7M | $117.3M |
| 净利润 | $-15.9M | $-8.5M |
| 毛利率 | 47.5% | 31.7% |
| 营业利润率 | -2.4% | — |
| 净利率 | -7.1% | -7.3% |
| 营收同比 | -2.8% | 5.3% |
| 净利润同比 | 96.5% | -43.1% |
| 每股收益（稀释后） | $-0.07 | $-0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NEOGSWIM
| Q1 26 | — | $117.3M | ||
| Q4 25 | $224.7M | $100.0M | ||
| Q3 25 | $209.2M | $161.9M | ||
| Q2 25 | $225.4M | $172.6M | ||
| Q1 25 | $221.0M | $111.4M | ||
| Q4 24 | $231.3M | $87.3M | ||
| Q3 24 | $217.0M | $150.5M | ||
| Q2 24 | $236.8M | $160.1M |
净利润NEOGSWIM
| Q1 26 | — | $-8.5M | ||
| Q4 25 | $-15.9M | $-7.0M | ||
| Q3 25 | $36.3M | $8.1M | ||
| Q2 25 | $-612.3M | $16.0M | ||
| Q1 25 | $-10.9M | $-6.0M | ||
| Q4 24 | $-456.3M | $-29.2M | ||
| Q3 24 | $-12.6M | $5.9M | ||
| Q2 24 | $-5.4M | $13.3M |
毛利率NEOGSWIM
| Q1 26 | — | 31.7% | ||
| Q4 25 | 47.5% | 28.0% | ||
| Q3 25 | 45.4% | 35.4% | ||
| Q2 25 | 41.2% | 37.1% | ||
| Q1 25 | 49.9% | 29.5% | ||
| Q4 24 | 49.0% | 24.6% | ||
| Q3 24 | 48.4% | 32.4% | ||
| Q2 24 | 47.9% | 33.1% |
营业利润率NEOGSWIM
| Q1 26 | — | — | ||
| Q4 25 | -2.4% | -10.7% | ||
| Q3 25 | -7.7% | 13.3% | ||
| Q2 25 | -271.1% | 14.3% | ||
| Q1 25 | 2.4% | -4.4% | ||
| Q4 24 | -197.8% | -14.9% | ||
| Q3 24 | 1.0% | 8.9% | ||
| Q2 24 | 5.5% | 12.5% |
净利率NEOGSWIM
| Q1 26 | — | -7.3% | ||
| Q4 25 | -7.1% | -7.0% | ||
| Q3 25 | 17.4% | 5.0% | ||
| Q2 25 | -271.6% | 9.3% | ||
| Q1 25 | -4.9% | -5.4% | ||
| Q4 24 | -197.3% | -33.4% | ||
| Q3 24 | -5.8% | 3.9% | ||
| Q2 24 | -2.3% | 8.3% |
每股收益（稀释后）NEOGSWIM
| Q1 26 | — | $-0.07 | ||
| Q4 25 | $-0.07 | $-0.06 | ||
| Q3 25 | $0.17 | $0.07 | ||
| Q2 25 | $-2.82 | $0.13 | ||
| Q1 25 | $-0.05 | $-0.05 | ||
| Q4 24 | $-2.10 | $-0.24 | ||
| Q3 24 | $-0.06 | $0.05 | ||
| Q2 24 | $-0.02 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $145.3M | — |
| 总债务越低越好 | — | $3.3M |
| 股东权益账面价值 | $2.1B | $396.7M |
| 总资产 | $3.4B | $856.4M |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资NEOGSWIM
| Q1 26 | — | — | ||
| Q4 25 | $145.3M | — | ||
| Q3 25 | $138.9M | — | ||
| Q2 25 | $129.0M | — | ||
| Q1 25 | $127.7M | — | ||
| Q4 24 | $140.2M | — | ||
| Q3 24 | $120.5M | — | ||
| Q2 24 | $170.9M | — |
总债务NEOGSWIM
| Q1 26 | — | $3.3M | ||
| Q4 25 | — | $279.8M | ||
| Q3 25 | — | $281.1M | ||
| Q2 25 | — | $281.5M | ||
| Q1 25 | — | $306.9M | ||
| Q4 24 | — | $281.5M | ||
| Q3 24 | — | $282.8M | ||
| Q2 24 | — | $282.4M |
股东权益NEOGSWIM
| Q1 26 | — | $396.7M | ||
| Q4 25 | $2.1B | $405.9M | ||
| Q3 25 | $2.1B | $408.4M | ||
| Q2 25 | $2.1B | $398.4M | ||
| Q1 25 | $2.7B | $381.1M | ||
| Q4 24 | $2.7B | $387.2M | ||
| Q3 24 | $3.1B | $416.6M | ||
| Q2 24 | $3.1B | $408.1M |
总资产NEOGSWIM
| Q1 26 | — | $856.4M | ||
| Q4 25 | $3.4B | $823.2M | ||
| Q3 25 | $3.4B | $844.4M | ||
| Q2 25 | $3.4B | $822.1M | ||
| Q1 25 | $4.0B | $824.6M | ||
| Q4 24 | $4.1B | $794.2M | ||
| Q3 24 | $4.5B | $853.4M | ||
| Q2 24 | $4.5B | $830.0M |
负债/权益比NEOGSWIM
| Q1 26 | — | 0.01× | ||
| Q4 25 | — | 0.69× | ||
| Q3 25 | — | 0.69× | ||
| Q2 25 | — | 0.71× | ||
| Q1 25 | — | 0.81× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | — | 0.68× | ||
| Q2 24 | — | 0.69× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.4M | $-47.7M |
| 自由现金流经营现金流 - 资本支出 | $7.8M | — |
| 自由现金流率自由现金流/营收 | 3.5% | — |
| 资本支出强度资本支出/营收 | 5.2% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-18.5M | — |
8季度趋势，按日历期对齐
经营现金流NEOGSWIM
| Q1 26 | — | $-47.7M | ||
| Q4 25 | $19.4M | $23.3M | ||
| Q3 25 | $10.9M | $51.0M | ||
| Q2 25 | $16.4M | $36.0M | ||
| Q1 25 | $19.5M | $-46.9M | ||
| Q4 24 | $40.3M | $6.2M | ||
| Q3 24 | $-17.9M | $37.2M | ||
| Q2 24 | $26.7M | $52.4M |
自由现金流NEOGSWIM
| Q1 26 | — | — | ||
| Q4 25 | $7.8M | $14.1M | ||
| Q3 25 | $-13.1M | $45.2M | ||
| Q2 25 | $349.0K | $29.1M | ||
| Q1 25 | $-13.4M | $-50.3M | ||
| Q4 24 | $23.1M | $-98.0K | ||
| Q3 24 | $-56.3M | $33.2M | ||
| Q2 24 | $2.5M | $47.9M |
自由现金流率NEOGSWIM
| Q1 26 | — | — | ||
| Q4 25 | 3.5% | 14.1% | ||
| Q3 25 | -6.3% | 27.9% | ||
| Q2 25 | 0.2% | 16.8% | ||
| Q1 25 | -6.1% | -45.2% | ||
| Q4 24 | 10.0% | -0.1% | ||
| Q3 24 | -26.0% | 22.1% | ||
| Q2 24 | 1.1% | 29.9% |
资本支出强度NEOGSWIM
| Q1 26 | — | — | ||
| Q4 25 | 5.2% | 9.2% | ||
| Q3 25 | 11.5% | 3.6% | ||
| Q2 25 | 7.1% | 4.0% | ||
| Q1 25 | 14.9% | 3.1% | ||
| Q4 24 | 7.4% | 7.2% | ||
| Q3 24 | 17.7% | 2.7% | ||
| Q2 24 | 10.2% | 2.8% |
现金转化率NEOGSWIM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.30× | 6.29× | ||
| Q2 25 | — | 2.25× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.32× | ||
| Q2 24 | — | 3.95× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NEOG
| Other | $109.2M | 49% |
| Bacterial And General Sanitation | $44.9M | 20% |
| Services | $25.7M | 11% |
| Natural Toxins And Allergens | $20.4M | 9% |
| Animal Care | $8.9M | 4% |
| Genomics Services | $6.3M | 3% |
| Biosecurity Products | $4.6M | 2% |
| Life Sciences | $1.4M | 1% |
SWIM
暂无分部数据
